EFTA00994036.pdf

DataSet-9 1 page 301 words document
👁 1 💬 0
📄 Extracted Text (301 words)
From: Richard Kahn To: Jeffrey Epstein <[email protected]> Subject: <no subject> Date: Fri, 01 Aug 2014 11:01:16 +0000 Not sure if this was sent to just me or both of us 11:32 wrote: >Jeffrey, as. A follow-up to our conversation, I focus almost exclusively >on turnaround companies. Typically turnarounds are prove me type >companies and they typically drift lower on momentum , barring no >catalysts. As we approach earnings for some of these companies, I expect >major turnarounds for several of these companies. To Highlight a few. >RIBT stock is down 99.5 percent. The co will report strong growth and >will double sales each year for the foreseeable future. The stock is a >10X over the next few years. RWC will report strong #s and also will >double in the next year. RDNT will report blow away#'s and our large >option position should go from a 150K loss to a 150k profit in a short >period of time. I expect 35-36mm ebitda and .12-.15 in earnings. Stock >should go from 5 to 9 or 10. TBIO, When they report , they should also >show growth. The stock is at an all-time low and should also double >shortly. These are my top 4 and as a result of the strong reports in the >next 2 weeks we should see a pickup of 300-500k in the next 2 weeks just >from these 4 names. Again turnarounds take patience. They typically go >down but when they hit the inflection point they can go 10X depending on >the duration and steepness of the growth curve. RIBT is 100 percent for >the next few years. They manufacture the healthiest food on the planet >and own proprietary technology. 35mm in sales going to 200mm in 2-3 >years. Talk to you tomorrow. Bruce. >Sent via BlackBerry from T-Mobile EFTA00994036
ℹ️ Document Details
SHA-256
71bfc1b64b44aedbc11a77da345add7128409ff7b523a4dd00f106c2feaf2191
Bates Number
EFTA00994036
Dataset
DataSet-9
Type
document
Pages
1

Community Rating

Sign in to rate this document

📋 What Is This?

Loading…
Sign in to add a description

💬 Comments 0

Sign in to join the discussion
Loading comments…
Link copied!